Chymotra at Spray
Marketer
Adroit Lifescience Pvt Ltd
Salt Composition
Minoxidil (5% w/v)
Overview Chymotra at Spray
Chymotra Spray, a vasodilator, stimulates hair growth in men experiencing androgenetic alopecia. Apply only to a clean, dry scalp as directed on the label or by your physician. Visible hair regrowth may take 2-4 months; initial growth might be fine, light, and inconspicuous. Exceeding the recommended dosage won't hasten results and may increase adverse reactions. Continuous use is vital for sustained hair growth. Consult your doctor if no improvement or worsening occurs after 4-6 months of treatment. Common side effects include itching, hypertrichosis, rash, and dermatitis. Accidental application elsewhere can cause unwanted hair growth; rinse thoroughly with water if contact occurs with eyes, mouth, or broken skin. Report persistent or bothersome side effects to your physician. Chymotra Spray is typically unsuitable for individuals under 18 or over 65, or those with hair loss stemming from medication (like chemotherapy), nutritional deficits, hypertension, or concurrent scalp treatments. Individuals with heart disease or circulatory issues should consult their doctor before use.
Uses of Chymotra at Spray
Managing Hair Thinning
Major Benefits of Chymotra at Spray:
Follow your doctor's instructions precisely regarding dosage and treatment length. Always refer to the product label for application details.
Common Side effects of Chymotra at Spray:
- Itching
- Chest pain
- Headache
- Hypertrichosis (excessive hair growth)
- Rash
- Dermatitis
- Hypersensitivity
- Weight gain
- Fluid retention
- Tachycardia
How to use Chymotra at Spray:
Follow your doctor's instructions precisely regarding dosage and treatment length. Always consult the product label for usage guidelines.
How Chymotra at Spray works:
Chymotra Spray, a potassium channel activator, promotes vasodilation, widening blood vessels. Consequently, topical scalp application boosts blood flow, delivering enhanced oxygen and nutrients to hair follicles. This improved supply combats hair follicle degeneration and stimulates new hair growth, thus addressing alopecia.
SAFETY ADVICE
AlcoholNone
No drug interactions identified.
PregnancyCONSULT YOUR DOCTOR
Employing Chymotra Spray during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Chymotra Spray while breastfeeding is likely unsafe. Available human data indicates potential transfer to breast milk, posing a risk to the infant. Therefore, Chymotra Spray is not advised for breastfeeding mothers.
DrivingNone
No known drug interactions.
KidneyNone
No drug interactions identified.
LiverNone
No drug interaction identified.
What if you forget to take Chymotra at Spray :
Should you forget a dose of Chymotra Spray, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Chymotra at Spray
| Label | Value |
|---|---|
| Type of Compound | Aromatic dialkylamines |
| Potential for Dependence | None. |
| Medication Classification | CUTANEOUS |
| Mechanism of Action | Potassium channel activator |


